Oricell Therapeutics Holdings Ltd. announced a $70 million series C1 round to expand its global footprint and speed clinical development of its CAR T therapies. The round was co-led by Beijing Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results